Massimo Santini mainly investigates Internal medicine, Cardiology, Atrial fibrillation, Heart disease and Anesthesia. The Internal medicine study which covers Surgery that intersects with Clinical trial. His Cardiology study frequently draws connections to other fields, such as Risk factor.
The concepts of his Atrial fibrillation study are interwoven with issues in Stroke and Prospective cohort study. Vasovagal syncope, Neurological disorder and Syncope is closely connected to Randomized controlled trial in his research, which is encompassed under the umbrella topic of Anesthesia. In his research on the topic of Heart failure, Ejection fraction and Ventricle is strongly related with QRS complex.
His scientific interests lie mostly in Internal medicine, Cardiology, Atrial fibrillation, Heart failure and Anesthesia. His study brings together the fields of Surgery and Internal medicine. His study in Cardiology concentrates on Cardiac resynchronization therapy, Cardioversion, Sinus rhythm, Ventricular tachycardia and QRS complex.
His Ventricular tachycardia research integrates issues from Implantable cardioverter-defibrillator, Tachycardia and Ventricular fibrillation. His Atrial fibrillation research is multidisciplinary, relying on both Stroke, Heart disease, Bradycardia and Ablation. Specifically, his work in Anesthesia is concerned with the study of Syncope.
His primary areas of study are Internal medicine, Cardiology, Atrial fibrillation, Heart failure and Cardiac resynchronization therapy. His study connects Surgery and Internal medicine. In most of his Cardiology studies, his work intersects topics such as Prospective cohort study.
The study incorporates disciplines such as Stroke, Fibrinolytic agent, Comorbidity and Antithrombotic in addition to Atrial fibrillation. Massimo Santini has researched Heart failure in several fields, including Survival rate, Heart rate variability, Retrospective cohort study and Intensive care medicine. The Cardiac resynchronization therapy study combines topics in areas such as Telemedicine, Ventricular rate and Asymptomatic.
Internal medicine, Cardiology, Atrial fibrillation, Heart failure and Implantable cardioverter-defibrillator are his primary areas of study. He works in the field of Internal medicine, focusing on Cause of death in particular. His Cardiology study frequently intersects with other fields, such as Univariate analysis.
His Atrial fibrillation study combines topics from a wide range of disciplines, such as Stroke, Fibrinolytic agent, Prospective cohort study and Hazard ratio. His studies deal with areas such as Survival rate, Framingham Risk Score, Retrospective cohort study and Intensive care medicine as well as Heart failure. His Implantable cardioverter-defibrillator research also works with subjects such as
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay
S Cazeau;C Leclercq;T Lavergne;S Walker.
The New England Journal of Medicine (2001)
Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione
Roberto Marchioli;Federica Barzi;Elena Bomba;Carmine Chieffo.
Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy
Barry J. Maron;Paolo Spirito;Win Kuang Shen;Tammy S. Haas.
N-3 Fatty Acids for the Prevention of Atrial Fibrillation After Coronary Artery Bypass Surgery: A Randomized, Controlled Trial
Leonardo Calò;Leopoldo Bianconi;Furio Colivicchi;Filippo Lamberti.
Journal of the American College of Cardiology (2005)
Doppler myocardial imaging to evaluate the effectiveness of pacing sites in patients receiving biventricular pacing
Gerardo Ansalone;Paride Giannantoni;Renato Ricci;Paolo Trambaiolo.
Journal of the American College of Cardiology (2002)
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation.
Robby Nieuwlaat;Alessandro Capucci;Gregory Y.H. Lip;S. Bertil Olsson.
European Heart Journal (2006)
A Short‐Term, Randomized, Double‐Blind, Parallel‐Group Study to Evaluate the Efficacy and Safety of Dronedarone versus Amiodarone in Patients with Persistent Atrial Fibrillation: The DIONYSOS Study
Jean-Yves Le Heuzey;Gaetano M. De Ferrari;David Radzik;Massimo Santini.
Journal of Cardiovascular Electrophysiology (2010)
Development and prospective validation of a risk stratification system for patients with syncope in the emergency department: the OESIL risk score
F. Colivicchi;F. Ammirati;D. Melina;V. Guido.
European Heart Journal (2003)
Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers.
Alessandro Capucci;Massimo Santini;Luigi Padeletti;Michele Gulizia.
Journal of the American College of Cardiology (2005)
Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events.
Giovanni L. Botto;Luigi Padeletti;Massimo Santini;Alessandro Capucci.
Journal of Cardiovascular Electrophysiology (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: